REGENSBURG, Germany--(BUSINESS WIRE)--Transcatheter Technologies GmbH, an emerging medical device company that is developing a third-generation transcatheter aortic valve implantation (TAVI) system—Trinity—announced today the successful 30-day follow-up results for a pilot study of its Trinity TAVI system that is designed to be the world’s first ‘truly repositionable’ and, therefore, best TAVI system.
Help employers find you! Check out all the jobs and post your resume.
